2021 CMSC Annual Meeting

Late Breaking-Disease-modifying therapy

Late Breaking-Disease-modifying therapy

US Real World Experience Switching from Infusion and S1P Therapies to Cladribine Tablets: A Single Center Study

Background: Multiple sclerosis (MS) is a chronic neurological disorder and a major cause of disability in young adults. Cladribine tablets...

Read More